Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Cost-effectiveness analysis of anticoagulation options for non-valvular atrial fibrillation in Iran ; volume:17 ; number:1 ; day:26 ; month:11 ; year:2024 ; pages:1-7 ; date:12.2024
BMC Research Notes / Biomed Central; 17, Heft 1 (26.11.2024), 1-7, 12.2024
- Urheber
-
Rezaei, Satar
Bavandpour, Maryam
Mobinizadeh, Mohammadreza
Daroudi, Rajabali
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-024-07004-2
- URN
-
urn:nbn:de:101:1-2502112156249.440964340040
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rezaei, Satar
- Bavandpour, Maryam
- Mobinizadeh, Mohammadreza
- Daroudi, Rajabali
- SpringerLink (Online service)
Ähnliche Objekte (12)
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation
Observational study of frailty in older Japanese patients with non-valvular atrial fibrillation receiving anticoagulation therapy
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
Psychiatric symptoms in patients with non-valvular atrial fibrillation
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation
Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran
Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation